Clinical trial
Ureteral Stent-related Pain and Mirabegron (SPAM) Trial
NCT02095665 is registered in ClinicalTrials.gov with Nova Scotia Health Authority as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ureteral Stent-related Pain and Mirabegron (SPAM) Trial
- Lead sponsor
- Nova Scotia Health Authority
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 1, 2014
- Completion date
- March 23, 2018
- Enrollment
- 22 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.